162 results on '"O'Reilly, R.J."'
Search Results
2. Treatment with Banked 3rd Party Donor Derived Virus Specific T Cells: The Advantages of Pre-Defined HLA restriction and Epitope Specificity
3. Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)
4. Durable responses to 3rd party viral specific T cells mediated by different patterns of engraftment
5. Comparison of two T-cell depletion methods of grafts from alternative donors for allogeneic hematopoietic cell transplantation of patients with fanconi anemia.
6. In T-cell lines dually sensitized with antigens from EBV and CMV or from EBV and WT1 the T-cells specific for CMV or WT1 are often restricted by hla alleles that differ from those restricting T-cells specific for EBV
7. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation
8. Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice
9. Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions
10. Primary Immune Deficiency Treatment Consortium (PIDTC) report
11. Storage of CD34-positive selected HPC
12. Final product composition after ex-vivo T-cell reduction: Miltenyi CliniMACS versus Baxter Isolex 300I in a large cohort of allogeneic trans-plant patients
13. Factors Contributing to Viral Infections and the Limited Efficacy of Adoptively Transferred Donor Derived Immunodominant Virus-Specific T-Cells in Recipients of Haploidentical Stem Cell Transplants
14. WT1-Specific T-Cell Responses Following T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocyte Infusions in Patients with High-Risk Multiple Myeloma
15. Allogeneic Stem Cell Transplantation for Sickle Cell Anemia (SCA) at MSKCC: A Single Institution Series
16. Fludarabine Based Preparative Regimen Can Secure a Second Hematopoietic Stem Cell Transplant After Initial Graft Rejection
17. Safety and Effectiveness of Intravenous Palivizumab for Prevention of Respiratory Syncytial Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
18. Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients
19. Retrospective Analysis of Standard Versus Mini-Dose Methotrexate in the Prevention of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplant Recipients
20. Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (DCBT) Is Associated with Unique Clinical Features Including a Higher Incidence of Grade III-IV Acute GVHD (aGVHD) in Children
21. Dose-Dependent and Epitope-Specific in Vivo Irradication of the Human Ovarian Carcinoma Cells Expressing the Willms Tumor Protein, WT1, in NOD/SCID Mice, by WT1 Specific T Cells Monitored by Bioluminescent Imaging
22. The Memorial Sloan-Kettering Experience With Allogeneic Stem Cell Transplantation For T Cell Non-Hodgkins Lymphomas
23. IL-15 Enhances in-vitro Expansion And Functional Activity Of Antigen-Specific Effector Memory T Cells (TEM) While Co-Expression Of IL-15 And IL-15 Rα On Antigen Presenting Cells Also Promotes Enrichment And Preferential Expansion Of Central Memory T-Cells (TCM)
24. Comparative Effectiveness Analysis Of CD34+Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts On Allogeneic Hematopoietic Cell Transplantation For Patients With Acute Myeloid Leukemia (AML) In Complete Remission
25. Adoptive Transfer Of EBV Specific T-Cells For Treatment Of Primary And Rituxan Resistant EBV Lymphomas Following Allogeneic Stem Cell Transplants (HSCT): Clinical, Viral And Immunologic Corelates
26. T-Cell Depleted Allografts From Unrelated Donors Confer A Low Risk Of Relapse On Patients With Hematologic Malignancies
27. Absolute Lymphocyte Count At Day 30 Predicts Survival In Recipients Of A T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
28. Human Colon Carcinoma Cells Expressing CMVpp65 Antigen: An IN-VIVO Model for Adoptive Immunotherapy Of CMV Disease
29. An Animal Model That Predicts Unit Engraftment in Double Unit Cord Blood Transplant Recipients.
30. Predictors for persistent cytomegalovirus reactivation after T‐cell‐depleted allogeneic hematopoietic stem cell transplantation
31. Invasive adenoviral infections in T‐cell‐depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir
32. Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
33. In vivo dual modality contemporaneous imaging of different tumor reactive T-cell subpopulations
34. The effects of cytotoxic and immunosuppressive agents on thymic reconstitution
35. Identification of novel WT1 epitopes by sensitization of human T cells with overlapping pentadecapeptides spanning the WT1 protein for the targeted adoptive immunotherapy of leukemia
36. Ten allele high-resolution DNA typing has a direct impact on the disease free survival (DFS) in pediatric recipients of T-cell depleted (TCD) unrelated donor (URD) hematopoietic stem cell transplant (HCT)
37. Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)
38. Hematopoietic stem cell transplantation for the treatment of fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell depleted grafts from alternative donors
39. Characterization of the tumor-specific activity of WT1 specific T cells generated in vitro from normal individuals by sensitization with WT1-peptide loaded autologous EBV transformed B cells
40. Examining cytotoxic effects on thymic reconstitution: a model
41. AML patients lacking kir ligand for donor KIR exhibit increased overall survival in HLA-identical sibling transplants
42. Immunologic aspects of hematopoietic stem-cell transplantation
43. Characteristics of human EBV-specific cytotoxic T lymphocytes utilized for adoptive immunotherapy of EBV-induced lymphoproliferations in xenografted SCID mice
44. The effect of donor leukocyte infusions on development of EBV specific immunity post-marrow transplantation
45. Bone marrow transplantation for myelodysplastic syndromes and secondary acute myelocytic leukemia
46. Long-Term Survival After T-Cell Depleted Allogeneic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia
47. Comparative Effectiveness Analysis Of CD34 + Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts On Allogeneic Hematopoietic Cell Transplantation For Patients With Acute Myeloid Leukemia (AML) In Complete Remission
48. IL-15 Enhances in-vitro Expansion And Functional Activity Of Antigen-Specific Effector Memory T Cells (T EM) While Co-Expression Of IL-15 And IL-15 Rα On Antigen Presenting Cells Also Promotes Enrichment And Preferential Expansion Of Central Memory T-Cells (T CM)
49. The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles
50. Evaluation of HLA-Haplotype Disparate Parental Marrow Grafts Depleted of T Lymphocytes by Differential Agglutination with a Soybean Lectin and E-Rosette Depletion for the Treatment of Severe Combined Immunodeficiency.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.